Adam Wilken

Neuropsych Account Manager @Neurocrine Biosciences

Peoria, IL, US

Responsibilities Include Neurology and Psychiatry Account Management, Account Training Responsibilities and Promotion Of Disease State Awareness as well as Representation of Neurocrine Biosciences FDA-Approved medication Indicated for the treatment of adults with the rare disease Tardive Dyskinesia (TD). Accounts Include but are not limited to: Adult Psychiatry and General Neurology Accounts/Practices, Movement Disorder Specialists, Psychiatric In-Pt Hospitals, Out-Patient Behavioral Health Facilities, Community Mental/Behavioral Health Centers, Community Medical Centers, County Health Departments, Long-term Behavioral Health Facilities, Behavioral/Therapy Case Managers, as well as Internal Medicine and Family Medicine HCP\'s. Specialty Pharmacy Rx Only 2020• 70+ Rxing HCP’s and almost 500 TRx’s per 13 Wks – Highest Rxer # and Rx Volume in the nation - 9/2020• 456%- Rxer Growth from Q4 2018 to Q3 2020• #1/214 Current Ranking – September 2020• Winner - 2 Shareholders Awards: 1H 2020 – Growth #2/214__ Volume #3/214 -1 of 3 in Nation to win both• #5/214 Ranking – Q2 2020 – G.A. 110%• #11/214 Ranking – Q1 2020 – G.A. 112%2019• Catalyst Club Winner -#2/221 Overall Finish Year-End • Winner – Shareholders Award: 2H 2019 – Volume #11/221__Growth #2/221• SPARK Contest -#2 Region Finish• #1/221 Ranking – Q4 2019 – G.A. – 122%• #2/221 Ranking – Q3 2019 – G.A. – 143% • Summer Sprint Contest -#1 Region Finish• #4/221 Ranking – Q2 2019 – G.A. – 149%• Winner – Shareholders Award: 1H 2019 – Growth #1/221• #2/221 Ranking – Q1 2019 – G. A. 210%2018• Q4 2018 – G.A. 158%• 456%- Rxer Growth from Q4 2018 to Q2 2020